18F-Fluorodeoxyglucose Positron Emission Tomography: Useful Technique for Predicting Malignant Potential of Gastrointestinal Stromal Tumors

[1]  H. Katoh,et al.  Evaluation of 18F-2-deoxy-2-fluoro-d-glucose Positron Emission Tomography for Gastric Cancer , 2004, World Journal of Surgery.

[2]  M. Sasaki,et al.  An analysis of the physiological FDG uptake pattern in the stomach , 2003, Annals of nuclear medicine.

[3]  D. Brewster,et al.  Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach , 2003, Histopathology.

[4]  R. Hustinx,et al.  PET scan imaging in oncology. , 2003, European journal of cancer.

[5]  A. D. Van den Abbeele,et al.  Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs). , 2002, European journal of cancer.

[6]  Misa Nakamura,et al.  Helpful parameter for malignant potential of gastrointestinal stromal tumors (GIST). , 2002, Japanese journal of clinical oncology.

[7]  A. D. Van den Abbeele,et al.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. , 2002, The New England journal of medicine.

[8]  S. Hirohashi,et al.  Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. , 2002, Human pathology.

[9]  G. Demetri,et al.  Clinical management of gastrointestinal stromal tumors: before and after STI-571. , 2002, Human pathology.

[10]  W. El-Rifai,et al.  Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. , 2002, Human pathology.

[11]  H. Kuwano,et al.  Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma , 2002, Cancer.

[12]  M D Blaufox,et al.  PET imaging in oncology. , 2000, Seminars in nuclear medicine.

[13]  J. Lasota,et al.  Gastrointestinal stromal tumors: recent advances in understanding of their biology. , 1999, Human pathology.

[14]  J Aoki,et al.  Accuracy of standardized uptake value measured by simultaneous emission and transmission scanning in PET oncology. , 1999, Nuclear medicine communications.

[15]  Edvardsson,et al.  Expression of c‐kit (CD117) and Ki67 provides information about the possible cell of origin and clinical course of gastrointestinal stromal tumours , 1999, Histopathology.

[16]  W. Vaalburg,et al.  Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. , 1998, British Journal of Cancer.

[17]  L. Kindblom,et al.  Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. , 1998, The American journal of pathology.

[18]  S. Hirota,et al.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. , 1998, Science.

[19]  P. Valk,et al.  Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. , 1995, The Annals of thoracic surgery.

[20]  R L Wahl,et al.  Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. , 1993, Radiology.

[21]  M. Miettinen,et al.  Gastrointestinal stromal tumors. An immunohistochemical study of cellular differentiation. , 1988, American journal of clinical pathology.

[22]  J. Lasota,et al.  Gastrointestinal stromal tumors – definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis , 2000, Virchows Archiv.

[23]  R. DeMatteo,et al.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. , 2000, Annals of surgery.

[24]  W. Chapman,et al.  Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. , 1996, American journal of surgery.